Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,182,638
Closed -$82.5M 90
2019
Q1
$82.5M Buy
2,182,638
+147,238
+7% +$5.49M 2.41% 13
2018
Q4
$74M Buy
2,035,400
+10,500
+0.5% +$323K 2.98% 9
2018
Q3
$69.5M Sell
2,024,900
-2,800
-0.1% -$90.3K 2.14% 14
2018
Q2
$65.4M Buy
2,027,700
+1,176,600
+138% +$40.6M 2.22% 13
2018
Q1
$24.5M Sell
851,100
-6,200
-0.7% -$163K 0.95% 35
2017
Q4
$18M Buy
+857,300
New +$15.5M 0.78% 42

Other funds holding IFRX

Redmile Group's IFRX Position: Q2 2019 in Review

Redmile Group sold out of InflaRx (IFRX) in Q2 2019, closing a stake of 2,182,638 shares — an estimated $82.5M sold.

Redmile Group first reported a position in IFRX in Q4 2017 and held it in 6 quarters. The position peaked at $82.5M in Q1 2019. 28 funds tracked by Wall St. Rank hold IFRX as of Q2 2019.

  • Redmile Group reported no remaining InflaRx position as of Q2 2019 after selling out during the quarter.
  • Redmile Group sold 2,182,638 InflaRx shares in Q2 2019, an estimated $82.5M.
  • Redmile Group first reported a position in InflaRx in Q4 2017 and held it in 6 quarters.
  • Redmile Group's InflaRx position peaked at $82.5M in Q1 2019.
  • 28 funds tracked by Wall St. Rank held InflaRx as of Q2 2019.

Based on Redmile Group's 13F filing for Q2 2019, filed 14 Aug 2019.